BioNTech SE Tax Expense Income At Applicable Tax Rate
BioNTech SE (BNTX) reported Tax Expense Income At Applicable Tax Rate of -EUR 330.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:TaxExpenseIncomeAtApplicableTaxRate · last filed 2026-03-10
| Period end | Tax Expense Income At Applicable Tax Rate 12 month | Tax Expense Income At Applicable Tax Rate 12 month as first filed |
|---|---|---|
| 2025-12-31 | -330.00M EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | -186.80M EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 321.80M EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 3.53B EUR 20-F · filed 2025-03-10 | |
| 2021-12-31 | 4.62B EUR 20-F · filed 2024-03-20 | |
| 2020-12-31 | -44.90M EUR 20-F · filed 2023-03-27 | -44.89M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | -55.20M EUR 20-F/A · filed 2022-10-26 | 55.24M EUR 20-F · filed 2020-03-31 |
| 2018-12-31 | -14.78M EUR 20-F · filed 2021-03-30 | 14.78M EUR 20-F · filed 2020-03-31 |
| 2017-12-31 | 26.52M EUR 20-F · filed 2020-03-31 |